证券日报网讯 11月26日晚间，宏和科技发布公告称，公司于近日收到中国证券监督管理委员会出具的 《关于同意宏和电子材料科技股份有限公司向特定对象发行股票注册的批复》（证监许可[2025]2545 号），主要内容如下："一、同意你公司向特定对象发行股票的注册申请。二、你公司本次发行应严格 按照报送上海证券交易所的申报文件和发行方案实施。三、本批复自同意注册之日起12个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时报告上海证券交易所并按有 关规定处理。" （文章来源：证券日报） ...

Market Overview - The market exhibited a fragmented low-volume trading pattern, with the Shanghai Composite Index slightly down by 0.15%, while the Shenzhen Component and ChiNext Index rose by 1.02% and 2.14% respectively. Approximately 3,600 stocks declined against over 1,600 that rose, with total trading volume reaching 1.7 trillion [1][3]. AI Hardware Sector - The AI hardware sector saw significant gains, with OCS continuing to strengthen and the CPO sector experiencing a collective rise. Key stocks such as Special Information and Zhongji Xuchuang hit new highs, while others like Saimicroelectronics and Yuxi Technology also saw substantial increases [4][6][7]. Consumer Sector - The consumer sector experienced a resurgence in the afternoon following the release of a plan by six departments aimed at enhancing the adaptability of consumer goods supply and demand. This plan anticipates the formation of three trillion-level consumption areas and ten billion-level consumption hotspots by 2027. Retail stocks like Dongbai Group and Sanjiang Shopping surged, with several stocks hitting the daily limit [9][10]. Shenzhen Local Stocks - Following the announcement of a financial support plan for enterprises in Guangdong, Shenzhen local stocks initially showed little reaction but later surged in the afternoon, led by stocks like Teli A and Shenhua A. The rally was partly driven by news regarding Vanke's debt situation and restructuring plans, which sparked interest in related local stocks [12][14][15][17]. Reader Culture - Reader Culture experienced a sudden surge of over 7% in the afternoon, closing with a 5.1% increase. The rise was attributed to heightened media attention surrounding figures like Luo Yonghao, suggesting that market movements may be influenced by social media trends rather than fundamental factors [20].

Group 1: Storage Market Dynamics - The storage spot market is experiencing strong demand, leading to continued price increases for finished products, despite high prices [1] - Customers with low inventory levels are gradually accepting new pricing agreements, providing manufacturers with confidence to raise prices [1] - The significant price increases are affecting retail markets, with online and offline retailers raising prices for memory modules and SSDs, potentially reducing consumer purchasing willingness [1] Group 2: DRAM Industry Forecast - According to TrendForce, the DRAM industry revenue is expected to grow by 30.9% quarter-on-quarter in Q3 2025, reaching $41.4 billion due to rising contract prices and increased shipment volumes [1] - The fourth quarter is anticipated to see a significant increase in contract prices, with conventional DRAM prices expected to rise by 45%-50% [1] - The overall contract prices for conventional DRAM and HBM combined are projected to increase by 50%-55% [1] Group 3: Medical Device Market Growth - The Chinese medical device market is projected to reach ¥1.22 trillion by 2025, with over 33,000 production enterprises expected by the end of 2024, marking a 27.8% increase from the end of the 13th Five-Year Plan [2] - The industry is transitioning from "catching up" to "running alongside and leading," supporting the "Healthy China" strategy [2] Group 4: Flu Season Impact on Pharmaceuticals - The flu season has started early in China, with a 237% increase in sales of Oseltamivir over the past week, and a 180% increase for Maviral [2] - The peak of the flu season is expected between mid-December and early January [2] Group 5: Cinema Industry Growth - As of October 2023, China has added 233 cinemas and 1,588 screens, totaling 15,438 operating cinemas and 92,556 screens nationwide [3] - County-level cinemas account for 21.06% of the total, while town cinemas make up 18.01% [3] Group 6: Innovations in Medical Technology - Novo Nordisk's Kyinsu, the world's first weekly insulin and GLP-1 receptor agonist combination, has been approved in the EU for adults with type 2 diabetes [3] - This innovation represents a significant advancement in diabetes treatment options [3] Group 7: Corporate Developments - Allianz Partners plans to lay off 1,500 to 1,800 employees over the next 12-18 months, primarily in call center roles due to automation [5] - Novartis announced plans to cut up to 550 jobs in Switzerland by the end of 2027 as part of production adjustments [5]

Group 1 - The core point of the article is that Honghe Technology has received a patent for a foam elimination device used in liquid recovery tanks, which may enhance its product offerings in the electronic materials sector [1] - As of the announcement, Honghe Technology's revenue composition for the year 2024 is as follows: electronic-grade glass fiber cloth accounts for 93.47%, electronic-grade glass fiber yarn accounts for 6.44%, and other businesses account for 0.1% [1] - The current market capitalization of Honghe Technology is 29.8 billion yuan [1]

Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]

证券代码：603256 证券简称：宏和科技 公告编号：2025-077 宏和电子材料科技股份有限公司 关于向特定对象发行 A 股股票获得中国证券监督管理委员会 同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 宏和电子材料科技股份有限公司（以下简称"公司"）于近日收到中国证券 监督管理委员会（以下简称"中国证监会"）出具的《关于同意宏和电子材料科 技股份有限公司向特定对象发行股票注册的批复》（证监许可[2025]2545 号）， 主要内容如下： 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时 报告上海证券交易所并按有关规定处理。" 公司将根据上述批复文件和相关法律法规的要求以及公司股东大会的授权， 在规定期限内办理本次向特定对象发行股票相关事宜，并及时履行信息披露义务。 敬请广大投资者注意投资风险。 特此公告。 宏和电子材料科技股份有限公司 董事会 2025 年 11 月 27 日 "一、同意你公司向特定对象发行股票的注册申请。 二、你 ...

关于获得发明专利的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 宏和电子材料科技股份有限公司（以下简称"公司"）于近日收到了国家知识产权 局颁发的《发明专利证书》，具体如下： 证书号：第8493433号 发明名称：一种处理液回收槽泡沫消除设备 证券代码：603256 证券简称：宏和科技 公告编号：2025-076 宏和电子材料科技股份有限公司 专利权人：宏和电子材料科技股份有限公司 授权公告日：2025年11月18日 专利权期限：二十年（自申请日起算） 本次发明专利的取得是公司在本领域重要核心技术的体现和延伸，本次专利的获 得不会对公司近期经营产生重大影响，但有利于进一步完善公司知识产权体系的布 局，从而提升公司的技术核心竞争力。 特此公告。 宏和电子材料科技股份有限公司 董事会 2025 年 11 月 27 日 专利号：ZL 2022 1 1676867.X 专利申请日：2022年12月26日 ...

宏和科技（603256）(603256.SH)发布公告，公司于近日收到中国证券监督管理委员会(简称"中国证监 会")出具的《关于同意宏和电子材料科技股份有限公司向特定对象发行股票注册的批复》(证监许可 [2025]2545号)，同意公司向特定对象发行股票的注册申请。 ...

Group 1 - The glass and fiberglass sector increased by 1.16% on November 26, with Honghe Technology leading the gains [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] - Key stocks in the glass and fiberglass sector showed varied performance, with Honghe Technology closing at 33.93, up 6.30% [1] Group 2 - The glass and fiberglass sector saw a net inflow of 346 million yuan from main funds, while retail investors experienced a net outflow of 171 million yuan [2] - The trading volume and turnover for key stocks in the sector were significant, with Zhongcai Technology recording a turnover of 2.13 billion yuan [2] - The main fund inflow for Honghe Technology was 190 million yuan, representing 13.24% of its total trading volume [3]

Group 1 - The core viewpoint of the news is that Honghe Technology's stock has increased by 5.14%, reaching a price of 33.56 CNY per share, with a trading volume of 689 million CNY and a turnover rate of 2.44%, resulting in a total market capitalization of 29.524 billion CNY [1] - Honghe Technology specializes in the research, production, and sales of mid-to-high-end electronic-grade fiberglass cloth, with its main business revenue composition being: thin cloth 37.30%, ultra-thin cloth 24.56%, extremely thin cloth 20.00%, special cloth 6.93%, thick cloth 6.54%, yarn 4.12%, and others 0.55% [1] Group 2 - From the perspective of fund holdings, one fund under Guotai Fund has a significant position in Honghe Technology, specifically the Guotai Zhixiang Technology Mixed Fund A, which held 47,000 shares in the second quarter, accounting for 4.06% of the fund's net value, ranking as the eighth largest holding [2] - The Guotai Zhixiang Technology Mixed Fund A was established on July 27, 2022, with a latest scale of 15.4933 million CNY, and has achieved a year-to-date return of 3.61%, ranking 6005 out of 8216 in its category, while its one-year return is 36.75%, ranking 1750 out of 7932 [2]